Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application.
about
Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design.Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches.Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.
P2860
Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hsp90 inhibitors, part 2: comb ...... virtual screening application.
@en
type
label
Hsp90 inhibitors, part 2: comb ...... virtual screening application.
@en
prefLabel
Hsp90 inhibitors, part 2: comb ...... virtual screening application.
@en
P2093
P2860
P356
P1476
Hsp90 inhibitors, part 2: comb ...... virtual screening application.
@en
P2093
Antonia Caroli
Federico Corelli
Richard B Wickersham
P2860
P304
P356
10.1021/CI400760A
P577
2014-03-04T00:00:00Z